Phase 1 Trial to Assess Safety of Radioactive Anti-CD33 Antibody in Advanced Myeloma
A Phase 1 trial will soon be assessing Actimab-M, an anti-CD33…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Patients Value Obamacare More Than General Public and Oppose Its Repeal, Survey Says
People with chronic diseases value the Affordable Care Act…
Natural Killer Cells Could Be Used to Treat Myeloma, Small Study Suggests
A new immunotherapy using natural killer cells showed promise…
ASCT Benefited Younger, Older Multiple Myeloma Patients Equally, Study Finds
Multiple myeloma patients older than 65 years benefit as…
Alkeran-based 4-drug Combo Gives Excellent Outcomes in Myeloma Patients Undergoing Transplants
A combination treatment of four drugs including the chemotherapy…
Revlimid for Myeloma After Stem Cell Transplant Gets Nod from EMA Panel
The use of Revlimid (lenalidomide) as a maintenance…
